Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2326-6066.cir-18-0885

PubMed Identifier: 31213473

Publication URI: http://europepmc.org/abstract/MED/31213473

Type: Journal Article/Review

Parent Publication: Cancer Immunology Research

Issue: 8

ISSN: 2326-6066